Literature DB >> 30604257

Early experience and learning curve of solo single-incision distal gastrectomy for gastric cancer: a review of consecutive 100 cases.

So Hyun Kang1, Yo-Seok Cho1, Sa-Hong Min1, Young Suk Park1, Sang-Hoon Ahn2,3, Do Joong Park1,4, Hyung-Ho Kim1,4.   

Abstract

BACKGROUND: Single-incision distal gastrectomy (SIDG) is technically difficult due to limited range of motion and unstable field of view. Solo surgery using a passive scope holder may be the key in allowing SIDG to be safer and efficient. We report our initial 100 cases of, to what we know, the world's first solo SIDG, and calculate the learning curve.
METHODS: Prospectively collected database of 100 patients clinically diagnosed as gastric cancer who underwent solo SIDG from October 2013 until July 2016 was analyzed. All the operations were held by a single surgeon with no assistants. A passive laparoscopic scope holder was used to fix the field of view.
RESULTS: The mean operation time was 120.6 ± 30.2 min, and the average estimated blood loss was 33.5 ± 55.7 ml. Average body mass index was 23.4 ± 2.9 kg/m2. The median hospital stay was 5 (4-14) days, and the mean number of retrieved lymph nodes was 56.0 ± 22.8. There was no conversion to multiport or open surgery. Early complication of Clavien-Dindo grade III or more was 3%. Learning curve was calculated on operation time, and showed that an experienced surgeon in SIDG required 20 cases or less in stabilizing the operation time for solo SIDG.
CONCLUSIONS: Solo SIDG seems to be feasible and safe. The stable field of view created by a scope holder provides a favorable environment for a finer and more consistent operation. In addition, manpower can also be saved without affecting the quality of surgery.

Entities:  

Keywords:  Gastrectomy; Laparoscopic surgery; Learning curve; Robotics; Stomach neoplasm

Year:  2019        PMID: 30604257     DOI: 10.1007/s00464-018-06638-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

1.  Intracorporeal overlap gastro-gastrostomy for solo single-incision pylorus-preserving gastrectomy in early gastric cancer.

Authors:  So Hyun Kang; Yo-Seok Cho; Sa-Hong Min; Young Suk Park; Sang-Hoon Ahn; Joong Do Park; Hyung-Ho Kim
Journal:  Surg Today       Date:  2019-05-21       Impact factor: 2.549

2.  Advantages of a robotic approach compared with laparoscopy gastrectomy for patients with high visceral fat area.

Authors:  Makoto Hikage; Keiichi Fujiya; Yuhei Waki; Satoshi Kamiya; Yutaka Tanizawa; Etsuro Bando; Akifumi Notsu; Masanori Terashima
Journal:  Surg Endosc       Date:  2022-03-16       Impact factor: 3.453

3.  Comparing the short-term outcomes and cost between solo single-incision distal gastrectomy and conventional multiport totally laparoscopic distal gastrectomy for early gastric cancer: a propensity score-matched analysis.

Authors:  Boram Lee; Sang Il Youn; Kanghaeng Lee; Yongjoon Won; Sahong Min; Yoon Taek Lee; Young Suk Park; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  Ann Surg Treat Res       Date:  2021-02-01       Impact factor: 1.859

4.  Intracorporeal Esophagojejunostomy during Reduced-port Totally Robotic Gastrectomy for Proximal Gastric Cancer: a Novel Application of the Single-Site® Plus 2-port System.

Authors:  Seohee Choi; Taeil Son; Jeong Ho Song; Sejin Lee; Minah Cho; Yoo Min Kim; Hyoung-Il Kim; Woo Jin Hyung
Journal:  J Gastric Cancer       Date:  2021-06-23       Impact factor: 3.720

5.  Reduced-port totally robotic distal subtotal gastrectomy for gastric cancer: 100 consecutive cases in comparison with conventional robotic and laparoscopic distal subtotal gastrectomy.

Authors:  Won Jun Seo; Taeil Son; Hyejung Shin; Seohee Choi; Chul Kyu Roh; Minah Cho; Hyoung-Il Kim; Woo Jin Hyung
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

6.  Evaluation of Reduced Port Laparoscopic Distal Gastrectomy Performed by a Novice Surgeon.

Authors:  Dong Jin Park; Eun Ji Lee; Gyu Youl Kim
Journal:  J Gastric Cancer       Date:  2021-06-29       Impact factor: 3.720

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.